阿波利波蛋白B-100的结构异质性
Altaira D Dearborn1, Alan T Remaley2, Joseph Marcotrigiano1
1Structural Virology Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
The FEBS journal
|February 17, 2026
概括
研究人员可视化了在低密度脂蛋白 (LDL) 上的阿波蛋白B-100 (apoB-100) 的结构及其与低密度脂蛋白受体 (LDLR) 的相互作用. 这种结构性洞察力有助于更好地理解心血管疾病机制.
科学领域:
- 结构生物学 结构生物学
- 心血管科学 心血管科学
- 生物化学 生物化学
背景情况:
- 心血管疾病 (CVD) 构成了严重的全球健康负担,影响了发病率和死亡率.
- 目前用于预防心血管疾病的药物策略通常针对低密度脂蛋白受体 (LDLR) 与低密度脂蛋白 (LDL) 上的阿波利波蛋白B-100 (apoB-100) 之间的相互作用.
- 了解这种相互作用的结构基础对于开发有效疗法至关重要.
研究的目的:
- 为了确定apob-100在LDL上的高分辨率结构.
- 阐明apoB-100与LDLR相互作用的结构基础.
- 研究apoB-100的结构异质性和形状灵活性.
主要方法:
- 使用冷电子显微镜 (cryo-EM) 来确定LDL上的apoB-100的结构.
- 在LDLR的缺席和存在的情况下进行了结构分析.
- 使用计算建模和可视化技术来解释结构特征.
主要成果:
- 结构显示,apoB-100的C端三分之二 (>3000个残留物) 缺乏显著的三级结构.
- ApoB-100在LDL表面形成两螺旋和β片,包裹着脂质核心.
- 这种LDLR结合域涉及周边β带和apoB-100的N端的多个位点.
- 观察到apob-100的结构异质性和多重构造.
结论:
- 阿波B-100独特的结构组织促进其与LDLR的相互作用.
- 观察到的结构灵活性可能使apoB-100能够结合不同大小的脂蛋白,并与其他分子相互作用.
- 这些发现为LDL代谢和心血管疾病的潜在治疗点提供了关键的结构性见解.
相关概念视频
Asymmetric Lipid Bilayer
10.2K
Biological membranes show uneven distribution of different types of lipids in the inner and outer layers, resulting in transverse asymmetric membranes. The treatment of the erythrocyte membrane with the enzyme phospholipase confirmed the asymmetric nature of the lipid bilayer. The enzyme hydrolyzes lipids into fatty acids and hydrophilic groups. The phospholipase acts only on the outer layer of the membrane, while the inner layer remains intact. The phospholipase treatment resulted in 80%...
10.2K
Protein Complexes with Interchangeable Parts
3.0K
Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
3.0K
Multiple Allele Traits
38.3K
The Concept of Multiple Allelism
38.3K
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
189
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
189
Membrane Fluidity
16.4K
Membrane fluidity is explained by the fluid mosaic model of the cell membrane, which describes the plasma membrane structure as a mosaic of components—including phospholipids, cholesterol, proteins, and carbohydrates—that gives the membrane a fluid character.
Mosaic nature of the membrane
The mosaic characteristic of the membrane helps the plasma membrane remain fluid. The integral proteins and lipids exist as separate but loosely-attached molecules in the membrane. The membrane is...
Mosaic nature of the membrane
The mosaic characteristic of the membrane helps the plasma membrane remain fluid. The integral proteins and lipids exist as separate but loosely-attached molecules in the membrane. The membrane is...
16.4K
Membrane Fluidity
176.3K
Cell membranes are composed of phospholipids, proteins, and carbohydrates loosely attached to one another through chemical interactions. Molecules are generally able to move about in the plane of the membrane, giving the membrane its flexible nature called fluidity. Two other features of the membrane contribute to membrane fluidity: the chemical structure of the phospholipids and the presence of cholesterol in the membrane.
176.3K


